XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway
View/ Open
Author
Chen, Xi
Iliopoulos, Dimitrios
Zhang, Qing
Tang, Qianzi
Greenblatt, Matthew B.
Hatziapostolou, Maria
Tam, Wai Leong
Mai, Junhua
Shen, Haifa
Hu, Dorothy Z.
Adoro, Stanley
Hu, Bella
Song, Minkyung
Tan, Chen
Landis, Melissa D.
Ferrari, Mauro
Shin, Sandra J.
Chang, Jenny C.
Liu, X. Shirley
Glimcher, Laurie H.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/nature13119Metadata
Show full item recordCitation
Chen, X., D. Iliopoulos, Q. Zhang, Q. Tang, M. B. Greenblatt, M. Hatziapostolou, E. Lim, et al. 2014. “XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway.” Nature 508 (7494): 103-107. doi:10.1038/nature13119. http://dx.doi.org/10.1038/nature13119.Abstract
Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization1. One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE12 and its substrate XBP13. Previous studies report UPR activation in various human tumors4-6, but XBP1's role in cancer progression in mammary epithelial cells is largely unknown. Triple negative breast cancer (TNBC), a form of breast cancer in which tumor cells do not express the genes for estrogen receptor, progesterone receptor, and Her2/neu, is a highly aggressive malignancy with limited treatment options7, 8. Here, we report that XBP1 is activated in TNBC and plays a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumor growth and tumor relapse and reduced the CD44high/CD24low population. Hypoxia-inducing factor (HIF)1α is known to be hyperactivated in TNBCs 9, 10. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105133/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347434
Collections
- HMS Scholarly Articles [17917]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)